AptaBio Therapeutics Inc.

Research AptaBio Therapeutics Inc. (293780.KQ) on Bullrun: market cap KRW 195.81B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker293780.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyKRW
Market capKRW 195.81B
Financial periodQ2 2026
RevenueKRW 1.60B
Net incomeKRW 1.12B
Free cash flow-KRW 2.64B
Gross margin61.0%

Valuation Snapshot

latest market cap is KRW 195.81B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 195.81B	n/a	n/a	n/a

Dividend history

About AptaBio Therapeutics Inc.

AptaBio Therapeutics Inc., a biopharmaceutical company, develops platform based drugs for intractable diseases. Its platforms include Oxidative stress modulation platform for developing therapeutic agents for diabetes complications, vascular diseases, neurodegenerative diseases, and intractable cancers by controlling oxidative stress; Cancer-associated fibroblast control platform for developing new anticancer drugs for intractable cancer;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

Dongwha Pharm.Co.,Ltd (000020.KS) Yuhan Corporation (000100.KS) Yuyu Pharma, Inc. (000220.KS) Ildong Holdings Co., Ltd. (000230.KS) Samil Pharmaceutical Co.,Ltd (000520.KS) Dong-A Socio Holdings Co., Ltd. (000640.KS) JW Pharmaceutical Corporation (001060.KS) SAMSUNG PHARM. Co., LTD. (001360.KS) Ahn-Gook Pharmaceutical Co., Ltd. (001540.KQ) Chong Kun Dang Holdings Corp. (001630.KS) Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) HANDOK Inc. (002390.KS)

Frequently asked questions

What is AptaBio Therapeutics Inc.'s market cap?

AptaBio Therapeutics Inc.'s market capitalization is KRW 195.81B.